LORICRIN and abscess: Since ClfB is exposed on the bacterial cell surface and interacts directly with loricrin, we propose that antibodies produced in response to vaccination with ClfB may provide a protective effect by promoting opsonophagocytosis and by interfering with binding of ClfB to its ligand loricrin, which we have shown is present within the damaged skin and thus delays and prevents formation of a robust abscess structure.